Implantation of phakic intraocular lenses (pIOLs) is a reversible refractive procedure, preserving the patient's accommodative function with minimal induction of higher order aberrations compared with corneal photoablative procedures. Despite this, as an intraocular procedure, it has potential risks such as cataracts, chronic uveitis, pupil ovalization, corneal endothelial cell loss, pigmentary dispersion syndrome, pupillary block glaucoma, astigmatism, or endophthalmitis. Currently, only two models of posterior chamber pIOLs are commercially available, the implantable collammer lens (STAAR Surgical Co.) and the phakic refractive lens (PRL; Zeiss Meditec). The number of published reports on the latter is very low, and some concerns still remain about its long-term safety. The present article reviews the published literature on the outcomes after PRL implantation in order to provide a general overview and evaluate its real potential as a surgical refractive option. © 2013 Macmillan Publishers Limited. All rights reserved.
CITATION STYLE
Pérez-Cambrodí, R. J., Piñero, D. P., Ferrer-Blasco, T., Cerviño, A., & Brautaset, R. (2013). The posterior chamber phakic refractive lens (PRL): A review. Eye (Basingstoke). Nature Publishing Group. https://doi.org/10.1038/eye.2012.235
Mendeley helps you to discover research relevant for your work.